comparison of pain relief power of desmopressin and pethidine in combination with diclofenac

Comparison of the effects of inhaled Desmopressin and Pethidine in combination with Diclofenac in relieving pain caused by renal colic

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20201214049708N1

Enrollment

Registered

2020-12-31

Start date

2020-12-08

Completion date

Unknown

Last updated

2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal colic. Unspecified renal colic

Interventions

Intervention 1: Intervention group: It is called group A. In this group, 40 people will be given 40 micrograms of inhaled desmopressin (manufactured by Sina Daru company called Desmex) in the form of

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with renal colic

Exclusion criteria

Exclusion criteria: Active gastrointestinal ulcer Renal Failure Hypothyroidism Systolic blood pressure under than 80 mmgh Asthma Emphysema BPH

Design outcomes

Primary

Measure	Time frame
The amount of pain caused by renal colic is measured by VAS (questionnaire). Timepoint: Asking the amount of pain and recording it in the questionnaire at the time before the intervention, 15 minutes and 30 minutes after the intervention. Method of measurement: Visual Analogue Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHanid Moslemi

The Islamic Azad University of Ardabil

Hamidmoslemi1782@gmail.com+98 45 3372 8020

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026